Lees, J. S. and Mark, P. B. (2022) Insights into vitamin K metabolism in chronic kidney disease: more complicated than kale deficiency. Kidney International, 101(2), pp. 216-219. (doi: 10.1016/j.kint.2021.11.022) (PMID:35065688)
Text
259848.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. 330kB |
Abstract
Vascular calcification is a major manifestation of cardiovascular disease in advanced chronic kidney disease and is inhibited by vitamin K–dependent proteins. Clinical trials of vitamin K supplementation in chronic kidney disease have failed to demonstrate benefits on vascular calcification. Recent laboratory, human, and animal studies have shown that vitamin K handling and metabolism in chronic kidney disease is complex and suggest vitamin K2 subtype supplementation in isolation is unlikely to have significant clinical impact.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Mark, Professor Patrick and Lees, Jennifer |
Authors: | Lees, J. S., and Mark, P. B. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
Journal Name: | Kidney International |
Publisher: | Elsevier |
ISSN: | 0085-2538 |
ISSN (Online): | 1523-1755 |
Published Online: | 19 January 2022 |
Copyright Holders: | Copyright © 2022 International Society of Nephrology |
First Published: | First published in Kidney International 101(2):216-219 |
Publisher Policy: | Reproduced in accordance with the copyright policy of the publisher |
University Staff: Request a correction | Enlighten Editors: Update this record